The 2026 Global Delphi Consensus says microbiome-targeted treatments should be part of acne care, with full expert agreement. Prevention and relapse prevention still lack enough proof to become standard recommendations. The microbiome is the community of microbes living on skin and in the gut. Nine experts from Africa, America, Asia and Europe reviewed research and completed an electronic survey to define terms, identify harmful and protective strains, and set priorities, as detailed in the consensus report in MDPI Pharmaceuticals.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What did the experts agree on?
- Do daily habits and skincare change the skin microbiome?
- What goes wrong on acne-prone skin?
- What do researchers still need to learn?
- What can you discuss with your dermatologist now?
What did the experts agree on?
MDPI Pharmaceuticals reports unanimous 100% agreement that the microbiome helps drive acne and that microbiome-targeted treatments should be adopted for management. That vote moves microbial care into mainstream planning rather than experimental theory. The panel reached 89% agreement that microbes influence acne severity.
The same 89% agreement supported a direct gut-skin effect, pointing research toward combined skin plus oral or systemic approaches. The panel also reached 89% agreement on potential probiotic benefits and on adding prebiotics, probiotics and postbiotics to acne therapy. Prebiotics feed helpful microbes, probiotics supply live helpful microbes, and postbiotics supply helpful microbial products.
Do daily habits and skincare change the skin microbiome?
Yes. Skincare products can shift the acne microbiome toward or away from balance. Daily product choices therefore matter for people with acne-prone skin, meaning skin that breaks out easily.
Diet, lifestyle, climate and pollution form the exposome that directly affects that microbial community. A high-sugar diet, short sleep, hot humid weather and heavy air pollution can each change the skin environment. Those exposures do not act the same day for everyone. Pattern tracking helps separate a true trigger from a coincidence, such as stress, travel, new makeup or seasonal change.
What goes wrong on acne-prone skin?
Acne is not simple overgrowth of Cutibacterium acnes. It involves loss of diversity among C. acnes phylotypes, meaning closely related strain groups, as explained in the Springer review in the American Journal of Clinical Dermatology. Harmful strain types expand while protective types shrink, and Staphylococcus balance also shifts.
That dysbiosis triggers innate immunity, the skin's fast first-line defense, and drives inflammation. This model explains why two people can carry C. acnes yet have very different skin. Strain mix, microbial balance and immune response matter more than bacterial count alone.
What do researchers still need to learn?
Microbiome-targeted primary prevention reached only 78% agreement. Maintenance treatment to avoid relapses reached 75%, marking both uses as promising but unproven. Methods also need work.
Researchers cite varied lab methods, few long-term studies and a narrow focus on bacteria, as described in the methods review in the International Journal of Molecular Sciences. Future work must track fungi, viruses and strain-level changes over time. That detail will show which microbial shifts start breakouts, which prolong them and which treatments keep balance longer.
What can you discuss with your dermatologist now?
Keep skincare gentle, consistent and anti-inflammatory, without harsh scrubbing or frequent product switching. A stable routine makes it easier to judge whether breakouts, dryness or stinging are improving. Bring a short record of sleep, diet changes, stress, travel, weather and pollution exposure.
That record helps the clinician link flares to exposures and adjust topical or systemic care. Recent 2026 treatment guidance notes topical probiotics may help by replacing pathogenic Type 1 C. acnes with physiologic Type 2 strains alongside anti-inflammatory skincare, as noted in the 2026 treatment overview in Next Steps in Dermatology.
- Ask whether a prebiotic, probiotic or postbiotic product fits your current regimen
- Ask how long to trial it before judging clearing, irritation or breakouts
- Ask what signs should prompt stopping, such as spreading redness, pain or swelling
You Might Also Like
- Skin Microbiome Outcomes in the 2026 Probiotic Acne Review: What Researchers Still Need to Learn for People With Acne-Prone Skin
- The 2026 Oral Probiotic and Topical Secretome Acne Trial Protocol: What Researchers Still Need to Learn for People With Acne-Prone Skin
- Why the 2026 Probiotic and Secretome Paper Reports No Trial Results Yet: What Researchers Still Need to Learn for People With Acne-Prone Skin